The Company
"We develop and license vaccines and novel technologies for vaccines and diagnostics."

Our flagship project is a patented enterovirus based preventive Type 1 Diabetes (T1D) vaccine, similar to the widely used enterovirus vaccine against polio. Our other projects include new treatments and diagnostics for Allergies, Asthma and Celiac Disease, all covered by patents and patent applications.